Support, patience, and expectancy: therapeutic options alongside intensified treatments for depression?
作者信息
Patten Scott B
机构信息
Editor-in-Chief Designate, The Canadian Journal of Psychiatry, Ottawa, Ontario; Professor, Departments of Community Health Sciences and Psychiatry, University of Calgary, Calgary, Alberta; Member, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta.
出版信息
Can J Psychiatry. 2014 Jul;59(7):347-8. doi: 10.1177/070674371405900701.
Abstract
摘要
相似文献
1
Support, patience, and expectancy: therapeutic options alongside intensified treatments for depression?
Can J Psychiatry. 2014 Jul;59(7):347-8. doi: 10.1177/070674371405900701.
2
Treatment-resistant depression in primary care across Canada.
Can J Psychiatry. 2014 Jul;59(7):349-57. doi: 10.1177/070674371405900702.
3
Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study.
Br J Psychiatry. 2012 Jan;200(1):45-51. doi: 10.1192/bjp.bp.110.086983. Epub 2011 Oct 20.
4
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
J Affect Disord. 2013 Sep 25;150(3):834-9. doi: 10.1016/j.jad.2013.03.012. Epub 2013 Apr 6.
5
Clinical characteristics and management of treatment-resistant depression.
J Clin Psychiatry. 2015 Nov;76(11):1569-70. doi: 10.4088/JCP.14l09462.
6
[Chronic depression--epidemiological data and therapeutic options].
Fortschr Neurol Psychiatr. 2014 Mar;82(3):155-71; quiz 172-3. doi: 10.1055/s-0034-1366027. Epub 2014 Mar 10.
7
The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method.
J Affect Disord. 2016 Nov 15;205:365-371. doi: 10.1016/j.jad.2016.08.019. Epub 2016 Aug 16.
8
A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
PLoS One. 2020 Sep 11;15(9):e0238843. doi: 10.1371/journal.pone.0238843. eCollection 2020.
9
Re: Treatment of perinatal mood and anxiety disorders: a review.
Can J Psychiatry. 2008 Mar;53(3):209; author reply 210. doi: 10.1177/070674370805300314.
10
Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders.
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:134-47. doi: 10.1016/j.pnpbp.2016.04.003. Epub 2016 Apr 9.
本文引用的文献
1
A sex-specific comparison of major depressive disorder symptomatology in the canadian forces and the general population.
Can J Psychiatry. 2014 Jul;59(7):393-8. doi: 10.1177/070674371405900707.
2
Incentives and disincentives for the treatment of depression and anxiety: a scoping review.
Can J Psychiatry. 2014 Jul;59(7):385-92. doi: 10.1177/070674371405900706.
3
Treatment-resistant depression in primary care across Canada.
Can J Psychiatry. 2014 Jul;59(7):349-57. doi: 10.1177/070674371405900702.
4
The treatment of nonmelancholic depression: when antidepressants fail, does psychotherapy work?
Can J Psychiatry. 2014 Jul;59(7):358-65. doi: 10.1177/070674371405900703.
Zotero 插件